Format

Send to

Choose Destination
See comment in PubMed Commons below
J Gen Intern Med. 2006 Apr;21(4):363-6.

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.

Author information

1
Department of Medicine, Santa Clara Valley Medical Center, San Jose, CA 95128, USA. salpeter@stanford.edu

Erratum in

  • J Gen Intern Med. 2008 Oct;23(10):1728.

Abstract

OBJECTIVE:

To assess the effect of hormone therapy (HT) on coronary heart disease (CHD) events in younger and older postmenopausal women.

DESIGN:

A comprehensive database search identified randomized-controlled trials of HT of at least 6 months' duration that reported CHD events, defined as myocardial infarction or cardiac death.

MEASUREMENTS:

The pooled odds ratios (ORs) for CHD events were reported separately for younger and older women, defined as participants with mean time from menopause of less than or greater than 10 years, or mean age less than or greater than 60 years.

MAIN RESULTS:

Pooled data from 23 trials, with 39,049 participants followed for 191,340 patient-years, showed that HT significantly reduced CHD events in younger women (OR 0.68 [confidence interval (C I), 0.48 to 0.96]), but not in older women (OR 1.03 [CI, 0.91 to 1.16]). Hormone therapy reduced events in younger women compared with older women (OR 0.66 [CI, 0.46 to 0.95]). In older women, HT increased events in the first year (OR 1.47 [CI, 1.12 to 1.92]), then reduced events after 2 years (OR 0.79 [CI, 0.67 to 0.93]).

CONCLUSIONS:

Hormone therapy reduces the risk of CHD events in younger postmenopausal women. In older women, HT increases, then decreases risk over time.

PMID:
16686814
PMCID:
PMC1484709
DOI:
10.1111/j.1525-1497.2006.00389.x
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central Icon for PubMed Health
    Loading ...
    Support Center